Skip to main content
. 2010 Sep 28;123(20):3576–3586. doi: 10.1242/jcs.070391

Fig. 7.

Fig. 7.

Plakoglobin regulates Src activity through ECM deposition. (A) Western blot analysis of the levels of activated Src [Src(Tyr416-P); Scr-p416] in PG+/− and PG−/− keratinocytes in steady state. (B) Western blot showing a decrease in activated Src in PG−/− cells on the ECM deposited by PG+/− cells 5 hours after replating. (C) Immunofluorescence showing more robust focal adhesions in PG−/− cells treated with the Src inhibitor PP2. Scale bar: 20 μm.